Ulrich U, Rossmanith W G
Department of Obstetrics and Gynecology, University of Ulm, Germany.
J Endocrinol Invest. 1994 May;17(5):351-3. doi: 10.1007/BF03348998.
Severe bleeding into the peritoneal cavity from a ruptured ovulatory follicle is a rare complication in women receiving anticoagulation therapy. A number of both surgical and non surgical methods have been proposed to solve this problem. We adopted a novel therapeutic approach in a 40-year old patient who presented with recurrent acute hemoperitoneum under anticoagulation therapy for combined cardiac valve disease. The hemoperitoneum was successfully managed twice by laparoscopy. The patient then received intranasal GnRH analogue treatment together with transdermal estradiol and oral medroxyprogesterone-acetate. In this way ovarian sex steroids were replaced while cessation of ovarian function was achieved by the hypogonadotrophic condition. At the end of this mode of treatment no recurrence of a hemoperitoneum was seen in our patient. We therefore suggest that considerable gains may be expected from this method for the management of recurrent acute peritoneal hemorrhage caused by ovulation bleeding in patients under anticoagulation therapy.
排卵卵泡破裂导致腹腔严重出血是接受抗凝治疗的女性中一种罕见的并发症。已经提出了许多手术和非手术方法来解决这个问题。我们对一名40岁的患者采用了一种新的治疗方法,该患者在接受联合心脏瓣膜病抗凝治疗时出现复发性急性血腹。通过腹腔镜检查成功地两次处理了血腹。然后,患者接受了鼻内GnRH类似物治疗,同时使用经皮雌二醇和口服醋酸甲羟孕酮。通过这种方式,在性腺功能减退状态下实现卵巢功能停止的同时,替代了卵巢性类固醇。在这种治疗方式结束时,我们的患者未出现血腹复发。因此,我们认为这种方法有望为抗凝治疗患者因排卵出血引起的复发性急性腹膜出血的管理带来显著益处。